Madrigal Pharmaceuticals, Inc.

About Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals is a biopharmaceutical company dedicated to delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease. Their mission is to halt or reverse liver scarring (fibrosis) and resolve MASH to prevent devastating complications like cirrhosis, liver failure, and premature mortality.

Products & Services

Rezdiffra™ (Resmetirom):The first and only U.S. FDA-approved treatment for metabolic dysfunction-associated steatohepatitis (MASH), aimed at treating the disease and preventing progression.

Specialties

Metabolic Dysfunction-Associated Steatohepatitis (MASH) treatment Liver disease therapeutics Innovative research in fibrosis and cirrhosis prevention

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 500000000 MR: - FA: 500 million FAN: 500000000	D: 2025-07-22 FD: 2025-07-22	1 investors
2	RT: Senior Secured Credit Facility T: - FT: Senior Secured Credit Facility	A: 500000000 MR: - FA: $500 million FAN: 500000000	D: 2025-07-22 FD: 2025-07-22	1 investors
3	RT: Debt T: - FT: Debt	A: 500000000 MR: - FA: $500 million FAN: 500000000	D: 2025-07-17 FD: 2025-07-17	-
4	RT: Public Offering T: - FT: Public Offering	A: 600000000 MR: - FA: $600 million FAN: 600000000	D: 2024-03-18 FD: 2024-03-18	8 investors
5	RT: Public Offering T: - FT: Public Offering	A: 500000000 MR: - FA: $500 million FAN: 500000000	D: 2024-03-18 FD: 2024-03-18	7 investors
6	RT: Public Offering T: - FT: Public Offering	A: 500000000 MR: - FA: $500 million FAN: 500000000	D: 2023-09-28 FD: 2023-09-28	5 investors

Debt Latest

2025-07-22

$500.0M

1 investor (Pro only)

Senior Secured Credit Facility 2025-07-22

$500.0M

Debt 2025-07-17

$500.0M

View 5 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Bill Sibold

CEO

D

David Soergel

Executive Vice President, Chief Medical Officer

R

Rebecca Taub

Founder, M.D.

M

Mardi C. Dier

Executive Vice President, Chief Financial Officer

C

Carole Huntsman

Executive Vice President, Chief Commercial Officer

C

Clint Wallace

Executive Vice President, Chief Human Resources Officer

View 20 more team members with Pro

Unlock Full Team Directory

Recent News